Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11390603
Crystalline forms of a biphenyl compound
granted -
US 11390600
Crystalline forms of C21H22Cl2N4O2
granted -
US 11390613
Azole analogues and methods of use thereof
granted -
US 11389566
Method and composition for treating inflammatory bowel disease
granted -
US 11389550
Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound
granted -
US 11389533
Method of treating inflammatory bowel disease
granted -
US 11389490
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 11389481
Allogeneic cell therapy of B cell malignancies using genetically engineered T cells targeting CD19
granted -
US 11389482
Cell preparation for extemporaneous use, useful for healing and rejuvenation in vivo
granted -
US 11389473
Magnesium-containing oxytocin formulations and methods of use
granted -
US 11389459
Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance
granted -
US 11389444
Methods of treating metabolic diseases with fused bicyclic pyrazoles
granted -
US 11389415
Methods of regulating cannabinoid receptor activity-related disorders and diseases
granted -
US 11389497
Pharmaceutical composition for treating cancer
granted -
US 11389386
Photochemically stable, non-leaching, bridged polysilsesquioxane based sunscreens
granted -
US 11389407
Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent
granted -
US 11389449
Treatment of metabolic syndrome with an sGC stimulator
granted -
US 11389544
Formation of functionalized cancer targeting nanoparticles by supramolecular co-assembly
granted -
US 11389480
Human monoclonal antibody targeting TNFR2 for cancer immunotherapy
granted -
US 11389485
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 11389432
Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
granted -
US 11389400
Aerosilization of stem cells or stem cell derivatives for pulmonary delivery
granted -
US 11389433
BRD4 inhibitor treatment of IgE-mediated diseases
granted -
US 11389396
Tumescent antibiotic injection for treatment of chronic skin and soft tissue infections
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.